Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use
Authors
Keywords
-
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-03-12
DOI
10.1161/circoutcomes.119.005894
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight
- (2019) So-Ryoung Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Effectiveness and Safety of Four Direct Oral Anticoagulants in Asians with Non-valvular Atrial Fibrillation
- (2019) Yi-Hsin Chan et al. CHEST
- Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation
- (2019) So-Ryoung Lee et al. STROKE
- Impact of the Health Insurance Coverage Policy on Oral Anticoagulant Prescription among Patients with Atrial Fibrillation in Korea from 2014 to 2016
- (2018) Young-Jin Ko et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017
- (2018) Junya Zhu et al. PHARMACOTHERAPY
- Effectiveness and Safety of Non–Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation
- (2018) Edin Basic et al. THROMBOSIS AND HAEMOSTASIS
- Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
- (2018) Yi‐Hsin Chan et al. Journal of the American Heart Association
- Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients
- (2018) Yan-Guang Li et al. Korean Circulation Journal
- Antithrombotic Therapy for Atrial Fibrillation
- (2018) Gregory Y.H. Lip et al. CHEST
- Edoxaban in Asian Patients With Atrial Fibrillation
- (2018) So-Ryoung Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan
- (2018) Tze-Fan Chao et al. CIRCULATION
- Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients
- (2018) Gregory Y.H. Lip et al. STROKE
- Outcomes After Use of Standard- and Low-Dose Non–Vitamin K Oral Anticoagulants in Asian Patients With Atrial Fibrillation
- (2018) Min Soo Cho et al. STROKE
- Quality of Anticoagulation with Warfarin in Korean Patients with Atrial Fibrillation and Prior Stroke: A Multicenter Retrospective Observational Study
- (2017) Keun-Sik Hong et al. Journal of Clinical Neurology
- Comparison of Propensity Score Methods and Covariate Adjustment
- (2017) Markus C. Elze et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Changing Landscape for Stroke Prevention in AF
- (2017) Menno V. Huisman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study
- (2017) So-Ryoung Lee et al. PLoS One
- Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation
- (2017) Myung-Jin Cha et al. STROKE
- Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
- (2017) Michał Mazurek et al. THROMBOSIS AND HAEMOSTASIS
- Stroke prevention in atrial fibrillation: Past, present and future
- (2017) Ben Freedman et al. THROMBOSIS AND HAEMOSTASIS
- Introduction to the Analysis of Survival Data in the Presence of Competing Risks
- (2016) Peter C. Austin et al. CIRCULATION
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
- (2016) A John Camm et al. HEART
- Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation
- (2016) Yi-Hsin Chan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation
- (2016) Yi-Hsin Chan et al. STROKE
- Dabigatran in real-world atrial fibrillation
- (2016) Francisco Moscoso Costa et al. THROMBOSIS AND HAEMOSTASIS
- Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin
- (2016) Allison Keshishian et al. THROMBOSIS AND HAEMOSTASIS
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2016) Torben Bjerregaard Larsen et al. BMJ-British Medical Journal
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2016) Torben Bjerregaard Larsen et al. BMJ-British Medical Journal
- Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011–2015 in Denmark
- (2016) Laila Staerk et al. Scientific Reports
- Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal
- (2015) Gregory Y.H. Lip et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
- (2015) Peter C. Austin et al. STATISTICS IN MEDICINE
- Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation
- (2015) Kang-Ling Wang et al. STROKE
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments
- (2013) Peter C. Austin STATISTICS IN MEDICINE
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
- (2010) Lars Wallentin et al. LANCET
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
- (2009) Peter C. Austin STATISTICS IN MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search